Allspring Global Investments Holdings, LLC Harmony Biosciences Holdings, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$59.4 Billion
Q2 2024

A detailed history of Allspring Global Investments Holdings, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 32,302 shares of HRMY stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,302

Previous 35,272 8.42%

Holding current value

$1.12 Million

Previous $1.18 Million 17.74%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$28.81 - $33.01 $85,565 - $98,039	-2,970 Reduced 8.42%	32,302 $974,000
Q1 2024 Apr 18, 2024	BUY	$29.93 - $35.06 $11,882 - $13,918	397 Added 1.14%	35,272 $1.18 Million
Q4 2023 Jan 25, 2024	SELL	$19.2 - $33.78 $292,915 - $515,347	-15,256 Reduced 30.43%	34,875 $1.13 Million
Q3 2023 Oct 27, 2023	BUY	$31.89 - $39.03 $1.6 Million - $1.96 Million	50,131 New	50,131 $1.64 Million
Q2 2023 Jul 18, 2023	BUY	$30.5 - $37.4 $403,362 - $494,615	13,225 Added 36.63%	49,327 $1.74 Million
Q1 2023 Apr 13, 2023	SELL	$30.8 - $53.92 $5.73 Million - $10 Million	-185,921 Reduced 83.74%	36,102 $1.18 Million
Q4 2022 Jan 23, 2023	BUY	$45.4 - $60.91 $4.46 Million - $5.98 Million	98,246 Added 79.37%	222,023 $0
Q3 2022 Oct 26, 2022	BUY	$42.06 - $55.45 $5.1 Million - $6.72 Million	121,174 Added 4655.17%	123,777 $5.48 Million
Q2 2022 Jul 25, 2022	SELL	$33.54 - $52.15 $319,669 - $497,041	-9,531 Reduced 78.55%	2,603 $126,000
Q1 2022 May 02, 2022	BUY	$33.14 - $51.13 $74,531 - $114,991	2,249 Added 22.75%	12,134 $590,000
Q4 2021 Jan 28, 2022	BUY	$34.09 - $43.91 $336,979 - $434,050	9,885 New	9,885 $421,000

Others Institutions Holding HRMY

# of Institutions

228

Shares Held

45.4M

Call Options Held

48.2K

Put Options Held

61.5K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.05B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Harmony Biosciences Holdings, Inc. Transaction History